Skip to content

Pilot study on supportive talk therapy for Parkinson's disease patients with deep brain stimulation

Pilot study on supportive talk therapy for Parkinson's disease patients with deep brain stimulation - SupportTHS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00028200
Enrollment
12
Registered
2022-02-21
Start date
2022-02-21
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G20.10

Interventions

Group 1: The intervention group consisting of 6 pairs of patients and relatives will receive supportive talk therapy consisting of 6 sessions spread over seven months. The sessions take place only par

Sponsors

Universitätsklinikum MarburgKlinik für Neurologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Patients with a clinical diagnosis of Parkinson's disease idiopathic syndrome. 2) Patients who will receive THS. 3) Patients between 30 and 80 years of age with German as their native language. 4) Patients with a MMST score of 25 points or higher. 5) Patients with a BDI-II score of up to 18 points. 6) Patients must be able to give consent and sign a consent form.

Exclusion criteria

Exclusion criteria: 1) Patients suffering from another disease affecting cognition (e.g. vascular events, tumors, etc.). 2) Participation in studies that could interfere with the present study, if this endangers or particularly burdens the participant or if this falsifies the results of the present or the other study or endangers others. 3) Patients who do not agree with the questioning of relatives.

Design outcomes

Primary

MeasureTime frame
Therapy adherence or number of sessions attended.

Secondary

MeasureTime frame
1) Evaluation of the concept of supportive talk therapy by patients and relatives. 2) Evaluation of the temporal extent of the intervention by patients and relatives. 3) Evaluation of the therapy modules or components and the overall evaluation of patients and relatives. 4) Change in the neuropsychological parameters of the patients in the intervention group compared to the control group.

Countries

Germany

Contacts

Public ContactFranziska Thieken

Universitätsklinikum MarburgKlinik für Neurologie

thieken@staff.uni-marburg.de06421-5865299

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026